文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

RECOVER队列中气管切开与功能、神经心理及医疗利用结局的关联

Association Between Tracheostomy and Functional, Neuropsychological, and Healthcare Utilization Outcomes in the RECOVER Cohort.
PubMed 文献 · Crit Care Explor · 2022-10-07
一句话结论在需机械通气≥7天的ICU幸存者中,气管切开患者住院死亡率更高(OR 2.6),1年内功能独立评分更低(FIM总分低7.7分)。

该研究为Towards RECOVER前瞻性观察研究的二次分析,纳入加拿大9个大学附属ICU中机械通气≥7天的内外科患者,比较气管切开(193/398,48.5%)与非气管切开患者的结局。气管切开患者年龄更大、机械通气时间和ICU/住院时间更长,ICU再入风险(OR 1.9)和住院死亡率(OR 2.6)更高,但1年死亡率无显著差异(HR 1.41,95%CI 0.88-1.2)。1年内气管切开患者FIM总分低7.7分,3个月起6MWT低12%、MRC评分低3.4分,多数肺功能指标低5-8%。气管切开患者出院时和1年时在家可能性更低。

要点

  • 需机械通气≥7天的ICU幸存者中,48.5%(193/398)接受气管切开,中位时间为ICU第14天(IQR 8-0天,原文如此)。
  • 气管切开患者住院死亡率更高(OR 2.6;95%CI 1.1-6.1),ICU再入风险更高(OR 1.9;95%CI 1.0-3.2),1年死亡率无显著差异(HR 1.41;95%CI 0.88-1.2)。
  • 1年内气管切开患者FIM总分低7.7分(95%CI 2.2-13.2),3个月起6MWT低12%(p=0.0008)、MRC评分低3.4分(p=0.006)。
  • 气管切开组多数肺功能指标低5-8%;SF36、IES、BDI-II两组相似。
  • 气管切开患者专科就诊率(率比0.63;95%CI 0.28-2.4)和再住院(OR 0.82;95%CI 0.54-1.3)相似,但出院时和1年时在家可能性更低。

适用人群与场景

  • 加拿大9个大学附属ICU中机械通气≥7天的内科/外科患者,纳入Towards RECOVER研究。
  • 二次分析纳入398例ICU幸存者,其中193例(48.5%)接受气管切开。

研究设计与关键结果

  • 研究设计:前瞻性观察研究的二次分析,比较气管切开与非气管切开患者;气管切开中位时间为ICU第14天(IQR 8-0天,原文如此)。
  • 气管切开患者年龄更大、病情严重程度相似、机械通气时间及ICU和住院时间更长。
  • 住院死亡率:气管切开组OR 2.6(95%CI 1.1-6.1);ICU再入OR 1.9(95%CI 1.0-3.2);1年死亡率HR 1.41(95%CI 0.88-1.2),无显著差异。
  • 1年内FIM总分:气管切开组低7.7分(95%CI 2.2-13.2);SF36、IES、BDI-II两组相似。
  • 3个月起6MWT:气管切开组低12%(p=0.0008);MRC评分低3.4分(p=0.006)。
  • 肺功能:气管切开组多数指标低5-8%。
  • 医疗利用:专科就诊率比0.63(95%CI 0.28-2.4),再住院OR 0.82(95%CI 0.54-1.3),均无显著差异;出院时和1年时在家可能性更低。

证据类型、等级与局限

  • 证据类型:前瞻性观察研究的二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于机械通气≥7天的ICU患者,气管切开与更高的住院死亡率(OR 2.6)和ICU再入风险(OR 1.9)相关,但1年死亡率无显著差异。
  • 气管切开患者1年内功能独立(FIM总分低7.7分)和运动能力(6MWT低12%、MRC低3.4分)更差,出院时和1年时在家可能性更低,提示需关注其出院安置和康复负担。
  • 气管切开组专科就诊和再住院率与非气管切开组相似。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: Tracheostomy is commonly performed in critically ill patients requiring prolonged mechanical ventilation (MV). We evaluated the outcomes of tracheostomy in patients who received greater than or equal to 1 week MV and were followed for 1 year.

DESIGN: In this secondary analysis of a prospective observational study, we compared outcomes in tracheostomy versus nontracheostomy patients. Outcomes post ICU included Functional Independence Measure (FIM) subscales, 6-Minute Walk Test (6MWT), Short Form 36 (SF36), Medical Research Council (MRC) Scale, pulmonary function tests (PFTs), Impact of Event Scale (IES), Beck Depression Inventory-II (BDI-II), and vital status and disposition.

SETTING: Nine University affiliated ICUs in Canada.

PATIENTS: Medical/surgical patients requiring MV for 7 or more days who were enrolled in the Towards RECOVER Study.

MEASUREMENTS AND MAIN RESULTS: Of 398 ICU survivors, 193 (48.5%) received tracheostomy, on median ICU day 14 (interquartile range [IQR], 8-0 d). Patients with tracheostomy were older, had similar severity of illness, had longer MV duration and ICU and hospital stays, and had higher risk of ICU readmission (odds ratio [OR], 1.9; 95% CI, 1.0-3.2) and hospital mortality (OR, 2.6; 95% CI, 1.1-6.1), but not 1-year mortality (hazard ratio, 1.41; 95% CI, 0.88-1.2). Over 1 year, tracheostomy patients had lower FIM-Total (7.7 points; 95% CI, 2.2-13.2); SF36, IES, and BDI-II were similar. From 3 months, tracheostomy patients had 12% lower 6MWT (p = 0.0008) and lower MRC score (3.4 points; p = 0.006). Most PFTs were 5-8% lower in the tracheostomy group. Tracheostomy patients had similar specialist visits (rate ratio, 0.63; 95% CI, 0.28-2.4) and hospital readmissions (OR, 0.82; 95% CI, 0.54-1.3) but were less likely to be at home at hospital discharge and 1 year.

CONCLUSIONS: Patients who received tracheostomy had more ICU and hospital care and higher hospital mortality compared with patients who did not receive a tracheostomy. In 1 year follow-up, tracheostomy patients required a higher daily burden of care, expressed by FIM.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Mehta S, Brondani A, Tomlinson G, et al. Association Between Tracheostomy and Functional, Neuropsychological, and Healthcare Utilization Outcomes in the RECOVER Cohort. Crit Care Explor. 2022. PMID: 36248317. doi:10.1097/CCE.0000000000000768

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。